A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (400 and 600mg/day) as Adjunctive Therapy in Subjects with Partial Seizures with or without Secondary Generalization

  • Fakhoury, Toufic (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date5/1/047/31/07